BE747656A - Compositions pharmaceutiques ameliorees comprenant un sel hydrosoluble d'un compose acide actif et un excipient hydrosoluble ( - Google Patents

Compositions pharmaceutiques ameliorees comprenant un sel hydrosoluble d'un compose acide actif et un excipient hydrosoluble (

Info

Publication number
BE747656A
BE747656A BE747656DA BE747656A BE 747656 A BE747656 A BE 747656A BE 747656D A BE747656D A BE 747656DA BE 747656 A BE747656 A BE 747656A
Authority
BE
Belgium
Prior art keywords
water
soluble
pharmaceutical compositions
acid compound
active acid
Prior art date
Application number
Other languages
English (en)
Inventor
J S Dwight
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BE747656A publication Critical patent/BE747656A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
BE747656D 1969-03-20 1970-03-19 Compositions pharmaceutiques ameliorees comprenant un sel hydrosoluble d'un compose acide actif et un excipient hydrosoluble ( BE747656A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB04670/69A GB1291281A (en) 1969-03-20 1969-03-20 Improvements in pharmaceutical compositions

Publications (1)

Publication Number Publication Date
BE747656A true BE747656A (fr) 1970-09-21

Family

ID=10045462

Family Applications (1)

Application Number Title Priority Date Filing Date
BE747656D BE747656A (fr) 1969-03-20 1970-03-19 Compositions pharmaceutiques ameliorees comprenant un sel hydrosoluble d'un compose acide actif et un excipient hydrosoluble (

Country Status (10)

Country Link
BE (1) BE747656A (fr)
DE (1) DE2013039A1 (fr)
DK (1) DK128674B (fr)
ES (1) ES377725A1 (fr)
FI (1) FI51653C (fr)
FR (1) FR2035118B1 (fr)
GB (1) GB1291281A (fr)
IL (1) IL34089A (fr)
NL (1) NL143419B (fr)
SE (1) SE379284B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2083622B1 (fr) * 1970-03-27 1975-08-22 Sankyo Co
US3969524A (en) * 1974-08-13 1976-07-13 Hoffmann-La Roche Inc. Stable amoxicillin dosage form
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
DE2965732D1 (en) * 1978-12-08 1983-07-28 Beecham Group Plc Pharmaceutical composition comprising a water soluble salt of amoxycillin and polyvinylpyrrolidone, and a vial containing a unit dose of said composition
CA2061520C (fr) * 1991-03-27 2003-04-22 Lawrence J. Daher Systeme de delivrance accelerant l'effet et accroissant la puissance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2438106A (en) * 1944-06-09 1948-03-23 Wyeth Corp Peroral penicillin compositions
US2864744A (en) * 1955-09-02 1958-12-16 American Home Prod Penicillin in solid dosage unit form
US3131123A (en) * 1959-03-13 1964-04-28 Lab Francais De Therapeutique Enteric tablets and manufacture thereof
GB1276839A (en) * 1968-08-02 1972-06-07 Sandoz Products Ltd Antibiotic compositions

Also Published As

Publication number Publication date
GB1291281A (en) 1972-10-04
FR2035118B1 (fr) 1974-08-30
FR2035118A1 (fr) 1970-12-18
NL143419B (nl) 1974-10-15
FI51653B (fr) 1976-11-30
ES377725A1 (es) 1972-10-16
FI51653C (fi) 1977-03-10
DE2013039A1 (de) 1970-09-24
DK128674B (da) 1974-06-17
IL34089A0 (en) 1970-05-21
NL7004004A (fr) 1970-09-22
SE379284B (fr) 1975-10-06
IL34089A (en) 1974-05-16

Similar Documents

Publication Publication Date Title
NL191150C (nl) N-(L-leucyl) doxorubicine en zuur-additiezouten daarvan, werkwijze ter bereiding en farmaceutische preparaat.
BE787771A (fr) Preparation d'acide glyoxylique
BE752813A (fr) Preparation d'acide trans-chrysanthemique optiquement actif
BE802700A (fr) Nouvelles compositions pharmaceutiques a base d'acide glycyrrhetinique
BE819294A (fr) Nouvelles compositions pharmaceutiques contenant de l'acide n-(2-furfuryl)-4-chloro-5-sulfamoyl-antranilique et leur procede de preparation
CA960668A (en) Preparation of 2-(6'-substituted-2'-naphthyl) propionic acid derivatives and salts thereof
BE747726A (fr) Preparation d'acide (+ ou -)-trans-chrysanthemique
BE747656A (fr) Compositions pharmaceutiques ameliorees comprenant un sel hydrosoluble d'un compose acide actif et un excipient hydrosoluble (
IL37467A0 (en) Derivatives of benzopyran-2-carboxylic acid,their preparation and pharmaceutical compositions containing them
BE769353A (fr) Derives de l'acide barbiturique et compositions en contenant
SE420919B (sv) Forfarande for framstellning av n?722-dansyl-l-argininderivat och farmaceutiskt godtagbara syradditionssalter derav
DK137681C (da) Insecticidt og acaricidt virksomme o-ethyl-s-n-propyl-o-vinyl-thionothiolphosphorsyreestere
BE747657A (fr) Compositions pharmaceutiques comprenant un sel hydrosoluble d'un compose acide actif et un acide carboxylique amino substitue (
BE808087A (fr) Preparation d'acide glyoxylique
BE792803A (fr) Derives d'acide 8,12-diisoprostanoique optiquement actifs, leurpreparation et compositions en contenant
BE844557A (fr) Nouveau sel de l'acide &-methyle benzoyl-5 thiophene-2 acetique, procede de preparation et compositions pharmaceutiques
IL34468A0 (en) Acid addition salts of indenopyridine derivatives,their preparation and pharmaceutical compositions containing them
BE796435A (fr) Compositions pharmaceutiques contenant des derives de l'acide benzoique
BE766354A (fr) Preparation d'esters d'acides organophosphoreux
IL37627A0 (en) 1,2,3,6-tetrahydro-4-pyridylmethyl esters of carboxylic acids and salts thereof,their preparation and pharmaceutical compositions containing them
GB1299037A (en) Dithiocarbamic acid esters
IL40623A (en) 14,15-dihydro-eburnamine-14-carboxylic acid derivatives and salts thereof,their preparation and pharmaceutical compositions containing them
BE745054A (fr) Preparation de derives d'acides phosphoniques
GB1287433A (en) Pharmaceutical compositions
BE768813A (fr) Acides aminoalkanoiques substitues, leurs sels acceptables pourl'usage pharmaceutique, leur preparation et leurs utilisations therapeutiques

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: PFIZER CORP.

Effective date: 19850319